Commonly used heart and diabetes drugs may improve mental health, study finds
January 10, 2019Research and Development UCL, bipolar, mental health, research, schizophrenia
Commonly used anti-cholesterol drugs, blood pressure drugs and medicines used for diabetes may improve the mental health of those with …
Amgen and UCB’s Evenity approved in Japan for osteoporosis
January 9, 2019Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma
Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …
Death row inmate whose execution was postponed found dead in cell
January 9, 2019Research and Development Alvogen, Scott Dozier, execution, pharma, prison
Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …
Super gonorrhoea on the rise, health officials warn
January 9, 2019Research and Development STI, gonorrehoea, health, public health, std
Health officials from Public Health England (PHE) have warned that cases of antibiotic resistant strains of the sexually transmitted infection …
Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk
January 9, 2019Manufacturing and Production, Research and Development India, Pfizer, pharma
Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …
Researchers explain link between anti-inflammatories and C. difficile
January 9, 2019Research and Development C diff, C.Diff, Vanderbilt, anti-inflammatory, cdi, nsaids, research
In the past, observational studies have found a link between the use of common nonsteroidal anti-inflammatory drugs (NSAIDs) and increased …
bluebird bio reveals new UK General Manager
January 9, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma
bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions, has named Nicola Redfern …
AstraZeneca hire controversial cancer doc to head new Oncology R&D unit
January 8, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology
The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
Two biomarkers can aid in atrial fibrillation screening, researchers find
January 8, 2019Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma
A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …
Government unveils £20bn plan to revitalise NHS in England
January 8, 2019Manufacturing and Production NHS funding, NHS< funding, brexit, government, health, policy
Theresa May and the chief executive of NHS England, Simon Stevens, have announced a new ten year plan for the …
Takeda completes Shire acquisition
January 8, 2019Manufacturing and Production M&A, MA, Shire, Takeda, acquisition, deal, pharma
Japanese firm Takeda Pharmaceuticals has successfully completed its acquisition of Shire Plc. The long anticipated deal has propelled the firm …
AbbVie records an estimated $4billion in impairment charges after failure of cancer drug Rova-T
January 8, 2019Manufacturing and Production AbbVie, M&A, MA, Stemcentrx, acquisition, rova-t
US firm AbbVie has said that it will record an estimated $4 billion in impairment charges related to the abandonment …
Immunocore names AstraZeneca exec as new CEO
January 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …
Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO
January 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon
The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …
Eli Lilly to buy Loxo Oncology in deal worth $8 billion
January 7, 2019Manufacturing and Production Cancer, Eli Lilly, Loxo Oncology, gene therapy, personalised medicine
US firm Eli Lilly & Co today announced a definitive agreement for the acquisition of Connecticut-based company Loxo Oncology in …
Roche’s Genentech inks potential $2bn personalised cancer drug development deal
January 7, 2019Sales and Marketing Adaptive Biotechnologies, Cancer, Genentech, Roche, oncology, pharma
Roche’s Genentech is set to enter into a deal with Adaptive Biotechnologies to bolster its pursuits in the treatment of …
How tech is powering precision treatment
January 7, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech
As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt
January 7, 2019Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease
Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …
AstraZeneca loses two senior executives as biotechs appoint new CEOs
January 7, 2019Sales and Marketing AstraZeneca, CEO, Ironwood Pharmaceuticals, biotech, immunocore
Two of AstraZeneca’s senior executives have been poached by the biotech firms Ironwood Pharmaceuticals and Immunocore, as the two biotechnology …
$400 billion in healthcare M&A deals expected for 2019
January 7, 2019Sales and Marketing Hong Kong, M&A, MA, biotech, deals pharma, law, mergers
The coming year is set to see mergers and acquisitions in the healthcare sector worth more than $400 billion, according …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
